NetworkNewsBreaks

FridayApr 04, 2025 2:34 pm

NetworkNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Working to Advance Innovation in the Future of Energy Storage

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) was featured in a recent article discussing its positioning at the forefront of lithium-sulfur (“Li-S”) battery innovation through its subsidiary, Lion Battery Technologies Inc. “Through strategic partnerships, dedicated research and development and a strong approach to intellectual property management, the company is working to make significant contributions to the future of energy storage,” the publication reads. “As lithium-sulfur batteries edge closer to commercial reality, PLG’s pioneering efforts position the company at the vanguard of this exciting technological frontier, ready to meet the energy challenges of tomorrow with solutions that are both powerful and…

Continue Reading

FridayApr 04, 2025 2:29 pm

NetworkNewsBreaks – ROTH Expands Healthcare Investment Banking Division with Key Appointments 

Roth Capital Partners, LLC ("ROTH"), www.roth.com, today announced its strategic appointment of Alex Nowak, CFA, as Managing Director, Healthcare Investment Banking, and Shelby Nowak, Vice President, Healthcare Investment Banking. Both will focus on the medical devices, diagnostics, and life science tools industries, reinforcing Roth's commitment to offering top-tier investment banking services in the healthcare sector.  “Alex's deep industry knowledge and strategic vision make him an excellent fit for ROTH. Additionally, Shelby's comprehensive industry insight will be instrumental in enhancing our investment banking capabilities. We are confident that his leadership will enhance our healthcare practice, and her approach to client engagement…

Continue Reading

FridayApr 04, 2025 1:03 pm

NetworkNewsBreaks – FAVO Capital Inc. (FAVO) Bringing Key Financing Options Tailored to Unique Dynamics of SMBs

FAVO (OTC: FAVO) is emerging as a powerful solutions provider for small and medium-sized businesses (“SMBs”) struggling with capital access. FAVO Capital leverages innovative financial products and data-driven technology to offer flexible, revenue-based financing options tailored to SMBs’ unique cash flow needs, bypassing the bureaucratic red tape of conventional institutions. Its alternative lending platform utilizes proprietary underwriting models to assess risk more accurately, reducing approval times and providing businesses with accessible, competitive funding options. Additionally, FAVO is developing a complementary mobile app to enhance the borrowing experience with real-time insights and personalized recommendations. Amid rising interest rates and stricter lending practices,…

Continue Reading

FridayApr 04, 2025 10:33 am

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Signs Partnership Deal With Charlotte FC to Boost Brand Visibility 

Nutriband (NASDAQ: NTRB), a developer of transdermal pharmaceutical products, has entered into an Associate Partnership agreement with Charlotte FC to raise awareness of its flagship brands, including AI Tape and AVERSA. The company plans to leverage the partnership to enhance exposure for AI Tape, which is manufactured in the Charlotte region through its Pocono Pharmaceutical subsidiary. Nutriband also aims to spotlight its AVERSA platform, touted as a potential first-in-class abuse-deterrent patch for chronic pain management.  To view the full press release, visit https://nnw.fm/8JpSb  About Nutriband Inc.  Nutriband is primarily engaged in the development of a portfolio of transdermal pharmaceutical products.…

Continue Reading

FridayApr 04, 2025 10:18 am

NetworkNewsBreaks – Tesla Inc. (NASDAQ: TSLA) Loses China Sales Crown to BYD as EV Competition Intensifies 

Tesla (NASDAQ: TSLA) has officially lost its position as the top-selling electric vehicle maker in China to rival BYD. In the first quarter of 2025, BYD sold 300,114 battery electric vehicles in China, outpacing Tesla's 294,218 units. This marks a shift in momentum for the Chinese automaker, which previously led globally in EV sales for Q4 2024 but now has firmly taken the domestic lead as well. The development underscores the growing pressure Tesla faces in the world’s largest EV market, where local competitors are rapidly scaling up production and offering more affordable models.  Tesla shares are trading lower, currently…

Continue Reading

FridayApr 04, 2025 9:40 am

NetworkNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG) Gains Momentum as Tariff Clarity Lifts Growth Stock Sentiment

Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) is seeing renewed investor interest following expectations that resolution around tariff policy could trigger a broader rally in growth stocks. Analysts point to the tech giant’s strong fundamentals and AI capabilities as key strengths that could help it lead a comeback among megacap growth names. After months of underperformance due to macro uncertainty and interest rate concerns, Alphabet is now being re-evaluated as a strategic holding amid shifting trade dynamics and improving investor sentiment. Alphabet shares are currently trading at $152.89, up $2.11 (1.40%) from the previous close as bullish momentum returns to the stock.…

Continue Reading

FridayApr 04, 2025 9:31 am

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) and Ford Otosan Launch Quantum Application to Boost Vehicle Production Efficiency

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, and Ford Otosan, a joint venture of Ford Motor Company and Koç Holding, announced the deployment of a hybrid-quantum application to optimize manufacturing for the Ford Transit line of vehicles. The system uses D-Wave’s annealing quantum computing to streamline vehicle production sequencing, cutting scheduling time for 1,000 vehicles from 30 minutes to under five minutes. The technology addresses the complexity of manufacturing over 1,500 Transit variants by improving throughput and flexibility in response to shifting demand and supply chain constraints. To view the full press…

Continue Reading

FridayApr 04, 2025 9:30 am

NetworkNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Raises US$2.4M to Launch Mill Construction at Montauban 

ESGold (CSE: ESAU) (OTCQB: ESAUF) has closed a non-brokered private placement totaling US$2.39 million (C$3.42 million), issuing nearly 16 million units at US$0.15 each. Proceeds will fund the start of mill circuit construction and final mobilization at the Company’s fully permitted Montauban Gold-Silver Project in Quebec. The raise included significant participation from New York-based hedge funds and family offices, with insider contributions from ESGold’s executive team. The financing marks a key milestone as ESGold moves into the final phase before production and continues deep exploration efforts through its ongoing ANT survey.   To view the full press release, visit https://nnw.fm/s7j22   About…

Continue Reading

FridayApr 04, 2025 9:30 am

NetworkNewsBreaks – Amazon.com Inc. (NASDAQ: AMZN) Faces Pressure as Tariff Concerns Spark $120 Price Target Revision

Amazon.com (NASDAQ: AMZN) could see its stock drop to $120 per share if proposed tariff hikes on Chinese goods materialize, according to a new analysis that examines the potential ripple effects on the e-commerce giant's operations and profit margins. The report highlights how Amazon’s cost structure—particularly for imported consumer goods—would be directly impacted, potentially forcing price hikes, margin compression, or both. With over 40% of Amazon’s product volume linked to Chinese imports, analysts warn that the company’s low-cost appeal and retail growth could be challenged by shifting trade dynamics. Amazon shares are currently trading at $182.14, down 0.9% on the…

Continue Reading

ThursdayApr 03, 2025 3:23 pm

NetworkNewsBreaks – Sunshine Biopharma Inc. (NASDAQ: SBFM) Secures $2.46M in Registered Direct 

Sunshine Biopharma (NASDAQ: SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, has closed its previously announced registered direct offering with institutional investors of approximately $2.46 million shares of common stock and pre-funded warrants at a price of $2.07 per share of common stock. The company received aggregate gross proceeds of approximately $2.46 million from the offering, of which it intends to use the net for general corporate purposes and working capital. Aegis Capital Corp. acted as exclusive placement agent for the offering. Sichenzia Ross Ference Carmel LLP acted as…

Continue Reading